Skip to main content

Table 2 Coadjuvant therapy

From: Sildenafil for treating patients with COVID-19 and perfusion mismatch: a pilot randomized trial

Treatment Sildenafil group (n = 20) Placebo group (n = 20) Total (n = 40)  
Dexamethasone (n, %) 17 (86%) 16 (80%) 33 (82.5%)  
Azithromycin (n, %) 4 (20%) 4 (20%) 8 (20%)  
Ceftriaxone (n, %) 16 (80%) 14 (70%) 30 (75%)  
Therapeutic anticoagulation (n, %) 2 (10%) 3 (15%) 5 (12.5%)